DZ2777A1 - Dérivés de quinazolinamines nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant. - Google Patents

Dérivés de quinazolinamines nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant.

Info

Publication number: DZ2777A1
Authority: DZ; Algeria
Prior art keywords: preparation; new; pharmaceutical compositions; compositions containing; derivatives process
Prior art date: 1998-04-29

Application number

DZ990077A

Other languages

English (en)

Inventor

Douglas John Meldrum Allen

Timothy Norris

Jeffrey William Raggon

Dinos Paul Santafianos

Ravi Mysore Shanker

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-04-29

Filing date

1999-04-28

Publication date

2003-12-01

1999-04-28 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2003-12-01 Application granted granted Critical

2003-12-01 Publication of DZ2777A1 publication Critical patent/DZ2777A1/fr

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Physical Education & Sports Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Dermatology (AREA)
Oncology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DZ990077A 1998-04-29 1999-04-28 Dérivés de quinazolinamines nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant. DZ2777A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US8344198P	1998-04-29	1998-04-29

Publications (1)

Publication Number	Publication Date
DZ2777A1 true DZ2777A1 (fr)	2003-12-01

Family

ID=22178359

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DZ990077A DZ2777A1 (fr)	1998-04-29	1999-04-28	Dérivés de quinazolinamines nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant.

Country Status (42)

Country	Link
EP (1)	EP1076652B1 (fr)
JP (1)	JP4652569B2 (fr)
KR (1)	KR100668412B1 (fr)
CN (2)	CN101219999A (fr)
AP (1)	AP1252A (fr)
AR (1)	AR018201A1 (fr)
AT (1)	ATE295839T1 (fr)
AU (1)	AU759691C (fr)
BR (1)	BR9910025A (fr)
CA (1)	CA2330447C (fr)
CO (1)	CO5060467A1 (fr)
CZ (1)	CZ298230B6 (fr)
DE (1)	DE69925366T2 (fr)
DZ (1)	DZ2777A1 (fr)
EA (1)	EA002836B1 (fr)
EG (1)	EG24000A (fr)
ES (1)	ES2238825T3 (fr)
GT (1)	GT199900063A (fr)
HK (1)	HK1037180A1 (fr)
HN (1)	HN1999000057A (fr)
HU (1)	HU227569B1 (fr)
ID (1)	ID27198A (fr)
IL (1)	IL139172A0 (fr)
MA (1)	MA26624A1 (fr)
ME (1)	MEP42008A (fr)
MX (1)	MXPA00010610A (fr)
MY (1)	MY136033A (fr)
NO (1)	NO317301B1 (fr)
NZ (1)	NZ508154A (fr)
OA (1)	OA11769A (fr)
PA (1)	PA8471001A1 (fr)
PE (1)	PE20000441A1 (fr)
PL (1)	PL196940B1 (fr)
RS (1)	RS50081B (fr)
SA (1)	SA99200216B1 (fr)
TN (1)	TNSN99079A1 (fr)
TR (1)	TR200003166T2 (fr)
TW (1)	TWI248437B (fr)
UA (1)	UA60363C2 (fr)
UY (1)	UY26099A1 (fr)
WO (1)	WO1999055683A1 (fr)
ZA (1)	ZA992972B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6706721B1 (en)	1998-04-29	2004-03-16	Osi Pharmaceuticals, Inc.	N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate
RS49836B (sr)	1999-03-31	2008-08-07	Pfizer Products Inc.,	Postupci i intermedijeri za dobijanje anti-kancernih jedinjenja
UA74803C2 (uk)	1999-11-11	2006-02-15	Осі Фармасьютікалз, Інк.	Стійкий поліморф гідрохлориду n-(3-етинілфеніл)-6,7-біс(2-метоксіетокси)-4-хіназолінаміну, спосіб його одержання (варіанти) та фармацевтичне застосування
US7087613B2 (en)	1999-11-11	2006-08-08	Osi Pharmaceuticals, Inc.	Treating abnormal cell growth with a stable polymorph of N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride
UA73993C2 (uk)	2000-06-06	2005-10-17	Астразенека Аб	Хіназолінові похідні для лікування пухлин та фармацевтична композиція
AU2002350105A1 (en)	2001-06-21	2003-01-08	Ariad Pharmaceuticals, Inc.	Novel quinazolines and uses thereof
US7078409B2 (en)	2002-03-28	2006-07-18	Beta Pharma, Inc.	Fused quinazoline derivatives useful as tyrosine kinase inhibitors
GB0223854D0 (en) *	2002-10-12	2002-11-20	Astrazeneca Ab	Therapeutic treatment
US7148231B2 (en)	2003-02-17	2006-12-12	Hoffmann-La Roche Inc.	[6,7-Bis(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)amine hydrochloride polymorph
MXPA05012939A (es)	2003-05-30	2006-05-17	Astrazeneca Uk Ltd	Procedimiento.
BRPI0411126A (pt)	2003-06-10	2006-07-18	Hoffmann La Roche	derivados de 1,3,4-triaza-fenaleno e 1,3,4,6-tetraazafenaleno
GB0403744D0 (en)	2004-02-20	2004-03-24	Astrazeneca Ab	Chemical process
WO2005107747A2 (fr)	2004-05-06	2005-11-17	Bioresponse, Llc	Preparations de diindolymethane destinee de traitement de leiomyomes
DE602005026328D1 (de)	2004-12-30	2011-03-24	Bioresponse Llc	Verwendung von diindolylmethan-verwandten indolen zur behandlung und prävention von erkrankungen im zusammenhang mit dem respiratory syncytial virus
CA2659307A1 (fr)	2006-07-28	2008-01-31	Synthon B.V.	Forme cristalline d'erlobtinib
BRPI0717753B1 (pt)	2006-10-27	2022-04-12	Bioresponse, Llc	Uso de uma composição compreendendo 50-250 mg de um ou mais indóis relacionados com dim e um ou mais agentes anti-protozoários, e, composição
WO2008122776A2 (fr) *	2007-04-04	2008-10-16	Cipla Limited	Procédé de préparation de l'erlotinib et de ses sels pharmaceutiquement acceptables
ES2492645T3 (es)	2007-07-11	2014-09-10	Hetero Drugs Limited	Un procedimiento mejorado para la preparación de hidrocloruro de erlotinib
EP2176241B1 (fr)	2007-08-17	2015-12-23	Hetero Drugs Limited	Nouvelle forme hydratée de base libre d'erlotinib et procédé de préparation de la forme polymorphe a de chlorhydrate d'erlotinib sensiblement exempte de la forme polymorphe b
KR101132937B1 (ko) *	2008-10-01	2012-04-06	주식회사종근당	Ｎ-(3-에티닐페닐)-6,7-비스(2-메톡시에톡시)-4-퀴나졸린아민 납실레이트 염
US8440823B2 (en)	2009-03-26	2013-05-14	Ranbaxy Laboratories Limited	Process for the preparation of erlotinib or its pharmaceutically acceptable salts thereof
WO2011068404A2 (fr)	2009-12-02	2011-06-09	Ultimorphix Technologies B.V.	Administration par inhalation de sel de mésylate de n-(3-éthynylphénylamino)-6,7-bis(2-méthoxyéthoxy)-4-quinazolinamine
DE202010006543U1 (de)	2010-05-07	2010-09-09	Ratiopharm Gmbh	Erlotinibresinat
HU230483B1 (hu)	2011-10-10	2016-07-28	Egis Gyógyszergyár Nyrt.	Erlotinib sók
WO2014037961A1 (fr)	2012-09-04	2014-03-13	Shilpa Medicare Limited	Procédé de préparation de la forme cristalline de chlorhydrate d'erlotinib

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ243082A (en) *	1991-06-28	1995-02-24	Ici Plc	4-anilino-quinazoline derivatives; pharmaceutical compositions, preparatory processes, and use thereof
JP2994165B2 (ja) *	1992-06-26	1999-12-27	ゼネカ・リミテッド	キナゾリン誘導体、その製造法および該キナゾリン誘導体を含有する抗癌作用を得るための医薬調剤
GB9323290D0 (en) *	1992-12-10	1994-01-05	Zeneca Ltd	Quinazoline derivatives
EP3103799B1 (fr) *	1995-03-30	2018-06-06	OSI Pharmaceuticals, LLC	Derives de quinazoline
US5747498A (en) *	1996-05-28	1998-05-05	Pfizer Inc.	Alkynyl and azido-substituted 4-anilinoquinazolines

1999
- 1999-04-08 OA OA1200000300A patent/OA11769A/en unknown
- 1999-04-08 JP JP2000545843A patent/JP4652569B2/ja not_active Expired - Lifetime
- 1999-04-08 EP EP99909165A patent/EP1076652B1/fr not_active Expired - Lifetime
- 1999-04-08 AT AT99909165T patent/ATE295839T1/de not_active IP Right Cessation
- 1999-04-08 ID IDW20002186A patent/ID27198A/id unknown
- 1999-04-08 ES ES99909165T patent/ES2238825T3/es not_active Expired - Lifetime
- 1999-04-08 NZ NZ508154A patent/NZ508154A/en not_active IP Right Cessation
- 1999-04-08 DE DE69925366T patent/DE69925366T2/de not_active Expired - Lifetime
- 1999-04-08 RS YUP-661/00A patent/RS50081B/sr unknown
- 1999-04-08 WO PCT/IB1999/000612 patent/WO1999055683A1/fr active IP Right Grant
- 1999-04-08 BR BR9910025-8A patent/BR9910025A/pt not_active Application Discontinuation
- 1999-04-08 KR KR1020007011998A patent/KR100668412B1/ko not_active IP Right Cessation
- 1999-04-08 EA EA200001112A patent/EA002836B1/ru not_active IP Right Cessation
- 1999-04-08 HU HU0101818A patent/HU227569B1/hu unknown
- 1999-04-08 MX MXPA00010610A patent/MXPA00010610A/es active IP Right Grant
- 1999-04-08 CZ CZ20003974A patent/CZ298230B6/cs not_active IP Right Cessation
- 1999-04-08 PL PL343766A patent/PL196940B1/pl not_active IP Right Cessation
- 1999-04-08 CA CA002330447A patent/CA2330447C/fr not_active Expired - Lifetime
- 1999-04-08 TR TR2000/03166T patent/TR200003166T2/xx unknown
- 1999-04-08 CN CNA2008100051101A patent/CN101219999A/zh active Pending
- 1999-04-08 IL IL13917299A patent/IL139172A0/xx not_active IP Right Cessation
- 1999-04-08 AU AU28509/99A patent/AU759691C/en not_active Expired
- 1999-04-08 ME MEP-420/08A patent/MEP42008A/xx unknown
- 1999-04-08 CN CN99805497A patent/CN1298396A/zh active Pending
- 1999-04-23 TW TW088106555A patent/TWI248437B/zh not_active IP Right Cessation
- 1999-04-26 HN HN1999000057A patent/HN1999000057A/es unknown
- 1999-04-27 PA PA19998471001A patent/PA8471001A1/es unknown
- 1999-04-27 MY MYPI99001636A patent/MY136033A/en unknown
- 1999-04-27 AR ARP990101942A patent/AR018201A1/es active IP Right Grant
- 1999-04-28 ZA ZA9902972A patent/ZA992972B/xx unknown
- 1999-04-28 TN TNTNSN99079A patent/TNSN99079A1/fr unknown
- 1999-04-28 MA MA25557A patent/MA26624A1/fr unknown
- 1999-04-28 DZ DZ990077A patent/DZ2777A1/fr active
- 1999-04-29 EG EG48299A patent/EG24000A/xx active
- 1999-04-29 CO CO99026003A patent/CO5060467A1/es unknown
- 1999-04-29 AP APAP/P/1999/001523A patent/AP1252A/en active
- 1999-04-29 PE PE1999000356A patent/PE20000441A1/es not_active Application Discontinuation
- 1999-04-29 GT GT199900063A patent/GT199900063A/es unknown
- 1999-06-02 SA SA99200216A patent/SA99200216B1/ar unknown
- 1999-08-04 UA UA2000116681A patent/UA60363C2/uk unknown
2000
- 2000-04-05 UY UY26099A patent/UY26099A1/es not_active Application Discontinuation
- 2000-10-27 NO NO20005453A patent/NO317301B1/no not_active IP Right Cessation
2001
- 2001-08-17 HK HK01105821A patent/HK1037180A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
UY26099A1 (es)	2001-12-28
DE69925366T2 (de)	2006-03-09
BR9910025A (pt)	2000-12-26
MEP42008A (en)	2011-02-10
NO20005453D0 (no)	2000-10-27
CA2330447C (fr)	2009-06-30
MA26624A1 (fr)	2004-12-20
CA2330447A1 (fr)	1999-11-04
EP1076652B1 (fr)	2005-05-18
NO317301B1 (no)	2004-10-04
PL196940B1 (pl)	2008-02-29
ES2238825T3 (es)	2005-09-01
AU2850999A (en)	1999-11-16
AP9901523A0 (en)	1999-06-30
DE69925366D1 (de)	2005-06-23
CN101219999A (zh)	2008-07-16
SA99200216B1 (ar)	2006-06-04
AR018201A1 (es)	2001-10-31
EP1076652A1 (fr)	2001-02-21
RS50081B (sr)	2009-01-22
HN1999000057A (es)	1999-09-29
HUP0101818A3 (en)	2002-05-28
OA11769A (en)	2005-07-25
PE20000441A1 (es)	2000-05-23
AU759691C (en)	2004-04-29
PA8471001A1 (es)	2000-09-29
UA60363C2 (uk)	2003-10-15
HUP0101818A1 (hu)	2002-03-28
ZA992972B (en)	2000-10-30
WO1999055683A1 (fr)	1999-11-04
CN1298396A (zh)	2001-06-06
EA200001112A1 (ru)	2001-04-23
KR20010078710A (ko)	2001-08-21
NO20005453L (no)	2000-12-20
MXPA00010610A (es)	2002-07-02
JP2002513009A (ja)	2002-05-08
CO5060467A1 (es)	2001-07-30
ID27198A (id)	2001-03-08
GT199900063A (es)	2000-10-20
ATE295839T1 (de)	2005-06-15
NZ508154A (en)	2003-07-25
JP4652569B2 (ja)	2011-03-16
EA002836B1 (ru)	2002-10-31
AU759691B2 (en)	2003-04-17
IL139172A0 (en)	2001-11-25
CZ20003974A3 (en)	2001-05-16
CZ298230B6 (cs)	2007-08-01
PL343766A1 (en)	2001-09-10
TNSN99079A1 (fr)	2005-11-10
TR200003166T2 (tr)	2001-02-21
MY136033A (en)	2008-07-31
YU66100A (sh)	2003-07-07
TWI248437B (en)	2006-02-01
EG24000A (en)	2008-03-19
AP1252A (en)	2004-02-25
HU227569B1 (en)	2011-08-29
KR100668412B1 (ko)	2007-01-12
HK1037180A1 (en)	2002-02-01

Publication	Publication Date	Title
DZ2891A1 (fr)	2003-12-15	Dérivés de tétrahydroquinoléines substués nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
MA26659A1 (fr)	2004-12-20	Dérivés de benzimidazole nouveaux, compositions pharmaceutiques les contenant et procédé pour leur préparation.
DZ1889A1 (fr)	2002-02-17	Dérivés de quinoléine nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2777A1 (fr)	2003-12-01	Dérivés de quinazolinamines nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2197A1 (fr)	2002-12-02	Dérivés de 6-phénylpyridyl-2-amine, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2963A1 (fr)	2004-03-15	Dérivés de bicycliques substituées nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ1957A1 (fr)	2002-02-17	Dérivés de pipéridine nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ3042A1 (fr)	2004-03-27	Dérivés d'isothiazole nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2758A1 (fr)	2003-09-15	Dérivés bicycliques d0acide hydroxamique nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2300A1 (fr)	2002-12-25	Dérivés 6,5-hétérobicycliques substitués, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2299A1 (fr)	2002-12-25	Dérivés 6,6-hétérobicycliques substitués, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2303A1 (fr)	2002-12-28	Dérivés d'indazole nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2962A1 (fr)	2004-03-15	Dérivés de 3-azabicycloÄ3,1,0Ühexane nouveaux, procédé pour leur préparation et compositions les contenant.
DZ3045A1 (fr)	2004-03-27	Dérivés de i 3-méthyl-érythromycine nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2773A1 (fr)	2003-12-01	Pyrazolopyrimidinones nouvelles procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2407A1 (fr)	2003-01-04	Dérivés de sulfonylurée procédé pour leur préparation et compositions pharmaceutiques les contenant
DZ2745A1 (fr)	2003-09-08	BicycloÄ2.2.1Üheptanes nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2128A1 (fr)	2002-10-26	Composés nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ3009A1 (fr)	2004-03-27	Dérivés de quinoléine-2-one à substituant hétéroaryle nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2634A1 (fr)	2003-03-08	Dérivés de pleuromutiline nouveaux procédé pour leur préparation et compositions pharmaceutiques lescontenant.
DZ2870A1 (fr)	2003-12-15	Dérivés d'acide hydroxypipécolate-hydroxamique nouveaux, procédé pour leur préparation et compositi ons pharmaceutiques les contenant.
DZ2890A1 (fr)	2003-12-15	4-Carboxamino-2-substitué-1,2,3,4-tétrahydroquinoléines, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2227A1 (fr)	2002-12-25	Dérivés d'indole nouveaux, procédé pour leur préparation et formulations pharmaceutiques les contenant.
DZ2581A1 (fr)	2003-02-22	Dérivés d'acides aryloxyarylsulfonylaminohydroxamiques procédé pour leur préparation et compositionspharmaceutiques les contenant.
MA26686A1 (fr)	2004-12-20	Derives de 4,4-biarylpiperidine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant